Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis

Published: Tuesday, June 25, 2013
Last Updated: Tuesday, June 25, 2013
Bookmark and Share
Company introduces Liberty Blue™ and Liberty XL™ microwave peptide synthesizer.

CEM Corporation has announced the introduction of a new family of products that significantly alters the paradigm of peptide synthesis from early discovery through pre-clinical studies.

The Liberty Blue™ line of research scale microwave peptide synthesizers and the Liberty XL™ mid-scale microwave peptide synthesizer were given an enthusiastic reception by attendees of the 23rd American Peptide Symposium in Waikoloa, Hawaii on Sunday, June 23rd.

The Liberty Blue technology allows for 4-minute cycle times and a 90% reduction in solvent usage compared to existing methods for making peptides.

The technology represents significant advances in hardware design, as well as remarkable improvements to the chemistry, resulting in greater speed and flexibility, better peptide purities and yields, and improved reliability.

“This is transformational technology that will dramatically change the world of peptide synthesis,” said Michael J. Collins, president and CEO of CEM Corporation. “It will provide the unprecedented ability to run the gamut of peptide synthesis from generating milligram amounts for lead optimization to building targeted libraries of peptides to producing 200-gram quantities for pre-clinical studies.”

“Cycle times are 10 times faster than current microwave synthesizers, allowing chemists to make a normal peptide in less than an hour. In addition, even with the fast cycle times, these new microwave peptide synthesizers produce peptides in unparalleled purities,” Collins continued.

The systems’ patent-pending Flex-Add™ Technology provides infinite volume delivery with a high degree of accuracy and precision, allowing the Liberty Blue line coverage of a wide scale range from 0.025 to 5 mmol, the broadest range of any line of research scale microwave peptide synthesizers. In addition, the chemistry is directly scalable up to 100 mmol with the new Liberty XL.

Designed for maximum speed, efficiency, and ease-of-use, the Liberty Blue line of microwave peptide synthesizers consists of manual, automated, and high-throughput systems, while the Liberty XL is an automated mid-scale system.

The systems feature CEM’s patented technology for using microwave energy for both the coupling and deprotection steps of the synthesis, ensuring higher purities and yields faster than ever before.

“We expect Liberty Blue and Liberty XL to have an even greater impact on peptide synthesis than the introduction of our original microwave peptide technology, which has become the method of choice for many researchers. These new products will give chemists the opportunity to once again push the boundaries of peptide synthesis,” concluded Collins.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

CEM Signs Exclusive Licensing Agreement with SpheriTech
The initial applications for these resins will focus on peptide synthesis.
Friday, February 28, 2014
New Book Chapter from CEM on Microwave Peptide Synthesis
Contribution of new chapter appears in Microwaves in Organic Synthesis, Volume 2.
Monday, June 17, 2013
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
A Crystal Clear View of Biomolecules
Fundamental discovery triggers paradigm shift in crystallography.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
"Dark Side" of the Transcriptome
New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Pumpjack" Mechanism for Splitting and Copying DNA
High-resolution structural details of cells' DNA-replicating proteins offer new insight into how these molecular machines function
The Power of Three
Overlooked portion of cell “death receptor” critical in some cancers, autoimmune diseases.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!